This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Rocket Doctor AI Grants Stock Options
Business stock grant

Rocket Doctor AI Grants Stock Options

Analysis based on 9 articles · First reported Jun 12, 2026 · Last updated Jun 12, 2026

Sentiment
10
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The granting of stock options and restricted share units by Rocket Doctor AI, Inc. could be seen positively by the market as a move to incentivize and retain talent, potentially leading to long-term growth. The extension of marketing services without additional compensation suggests a continued focus on investor awareness, which may help maintain or increase visibility for Rocket Doctor AI, Inc. in the market.

Healthcare Technology
Event Summary

Rocket Doctor AI, Inc. has granted 47,013 stock options and 514,801 restricted share units to its consultants and employees. These grants are part of the company's share compensation plans and are subject to vesting provisions and a statutory hold period. Additionally, Rocket Doctor AI, Inc. extended its digital marketing and investor awareness services agreements with 45 Degrees, Inc. and Investment Publishing LLC until September 30, 2026, without any further compensation.

Entities Involved
priv
Rocket Doctor AI, Inc.
Rocket Doctor AI, Inc. granted stock options and restricted share units to its consultants and employees, and extended marketing services agreements, which could positively impact employee retention and investor awareness.
Importance 100.0 Sentiment 10.0
priv
45 Degrees, Inc.
45 Degrees, Inc. had its marketing services agreement with Rocket Doctor AI, Inc. extended until September 30, 2026, without additional compensation.
Importance 20.0 Sentiment 0.0
priv
Investment Publishing LLC
Investment Publishing LLC had its marketing services agreement with Rocket Doctor AI, Inc. extended until September 30, 2026, without additional compensation.
Importance 20.0 Sentiment 0.0
per
Essam Hamza
Essam Hamza is the CEO of Rocket Doctor AI, Inc. and is mentioned as a contact for additional information.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.